Experimental pill aims to ease tough schizophrenia symptoms
NCT ID NCT02477670
First seen May 13, 2026 · Last updated May 13, 2026
Summary
This study tested an experimental drug called AVP-786 in 145 adults with schizophrenia who still had troubling symptoms despite taking their usual antipsychotic medication. The goal was to see if adding AVP-786 could reduce negative symptoms like lack of motivation and social withdrawal. Participants took either the drug or a placebo for 12 weeks, and researchers measured changes in symptom scores and checked for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Cerritos, California, United States
-
Study site
Garden Grove, California, United States
-
Study site
National City, California, United States
-
Study site
Oakland, California, United States
-
Study site
San Diego, California, United States
-
Study site
Washington D.C., District of Columbia, United States
-
Study site
Orlando, Florida, United States
-
Study site
Atlanta, Georgia, United States
-
Study site
Augusta, Georgia, United States
-
Study site
Chicago, Illinois, United States
-
Study site
Boston, Massachusetts, United States
-
Study site
Worcester, Massachusetts, United States
-
Study site
Grand Rapids, Michigan, United States
-
Study site
Marlton, New Jersey, United States
-
Study site
Jamaica, New York, United States
-
Study site
New York, New York, United States
-
Study site
Rochester, New York, United States
Conditions
Explore the condition pages connected to this study.